Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

In June, Esperion Therapeutics Inc. (NASDAQ:ESPR), an Ann Arbor-based early-stage pharmaceutical company, raised $73 million in its IPO. It plans a secondary offering this year, based on trial results of its cholesterol-lowering drug. Esperion Therapeutics Inc (NASDAQ:ESPR) stock performance was -5.04% in last session and finished the day at $14.69. Traded volume was 31,400 shares in the last session and the average volume of the … Continue reading Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

John Bellich08/1408/14

Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the “Company” or “La Jolla”) a leader in the development of therapeutics targeting significant unmet life-threatening diseases today announced that George Tidmarsh M.D. Ph.D. President and Chief Executive Officer will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its … Continue reading Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

Jayne Crisman08/1208/12

Best Stocks – La Jolla Pharmaceutical Company (NASDAQ:LJPC) , Nektar Therapeutics (NASDAQ:NKTR) , International Tower Hill Mines (NYSEMKT:THM) , Lions Gate Entertainment (NYSE:LGF)

In a research report released on Wednesday, Noble Financial lifted price target for La Jolla Pharmaceutical Company (NASDAQ:LJPC) stock from $34 per share to $38 per share. La Jolla Pharmaceutical Company (NASDAQ:LJPC) stock performance was 1.88% in last session and finished the day at $10.85. Traded volume was 271,034.00million shares in the last session and the average volume of the stock remained 127.48K shares. The … Continue reading Best Stocks – La Jolla Pharmaceutical Company (NASDAQ:LJPC) , Nektar Therapeutics (NASDAQ:NKTR) , International Tower Hill Mines (NYSEMKT:THM) , Lions Gate Entertainment (NYSE:LGF)

John Bellich07/1507/15

Trending Tickers – La Jolla Pharmaceutical Company (NASDAQ:LJPC) , Trex Company, Inc. (NYSE:TREX) , ResMed Inc. (NYSE:RMD), StemCells Inc (NASDAQ:STEM)

La Jolla Pharmaceutical Company (NASDAQ:LJPC) filed an S-3 on June 27 for a stock-and-warrant offering of $150M.Wedbush raises its PT to $45 from $34, representing a ~4x rise from today’s price. This is a clear signal that it is an underwriter on the issue. La Jolla Pharmaceutical Company (NASDAQ:LJPC) stock performance was 18.99% in last session and finished the day at $10.65. Traded volume was … Continue reading Trending Tickers – La Jolla Pharmaceutical Company (NASDAQ:LJPC) , Trex Company, Inc. (NYSE:TREX) , ResMed Inc. (NYSE:RMD), StemCells Inc (NASDAQ:STEM)

John Meady07/1407/14

Biotech gainers: Insmed Incorporated (NASDAQ:INSM), Prothena Corporation (NASDAQ:PRTA), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Biota Pharmaceuticals (NASDAQ:BOTA)

Some days before, shares of Insmed Incorporated (NASDAQ:INSM) fell double digits after the company reported data on a 90 patient Phase 2 trial. Insmed Incorporated (NASDAQ:INSM) stock performance was 7.02% in last session and finished the day at $13.41. Traded volume was 1.55million shares in the last session and the average volume of the stock remained 788.23K shares. The beta of the stock remained 0.69. … Continue reading Biotech gainers: Insmed Incorporated (NASDAQ:INSM), Prothena Corporation (NASDAQ:PRTA), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Biota Pharmaceuticals (NASDAQ:BOTA)

John Bellich04/1804/18

FB Nasdaq FB Facebook

Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Shares of Agenus Inc (NASDAQ:AGEN) , a biopharmaceutical company focused on developing novel immunotherapies to treat cancer and a number of other unmet diseases, tumbled by as much as 22% after partner GlaxoSmithKline (NYSE: GSK ) announced that its phase 3 MAGE-A3 cancer immunotherapeutic trial in non-small cell lung cancer (NSCLC) patients didn’t meet its first or second coprimary endpoint. Agenus Inc (NASDAQ:AGEN) stock performance … Continue reading Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Kevin Long03/2103/21